Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Fusidic acid poisoning |
Causative agent (attribute) |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
1 |
Accidental fusidic acid poisoning |
Causative agent (attribute) |
False |
Fusidic acid (substance) |
Inferred relationship |
Some |
|
Intentional fusidic acid poisoning |
Causative agent (attribute) |
False |
Fusidic acid (substance) |
Inferred relationship |
Some |
|
intoxication par l'acide fusidique d'intention indéterminée |
Causative agent (attribute) |
False |
Fusidic acid (substance) |
Inferred relationship |
Some |
1 |
Fusidic acid adverse reaction |
Causative agent (attribute) |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
1 |
Allergy to fusidic acid |
Causative agent (attribute) |
False |
Fusidic acid (substance) |
Inferred relationship |
Some |
|
Fusidic acid overdose |
Causative agent (attribute) |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
1 |
Accidental fusidic acid overdose |
Causative agent (attribute) |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
1 |
Intentional fusidic acid overdose |
Causative agent (attribute) |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
1 |
surdose de acide fusidique d'intention indéterminée |
Causative agent (attribute) |
False |
Fusidic acid (substance) |
Inferred relationship |
Some |
1 |
Fusidic acid 50 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fusidic acid (substance) |
Inferred relationship |
Some |
|
Fusidic acid [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fusidic acid (substance) |
Inferred relationship |
Some |
|
Fusidic acid 1% m/r eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fusidic acid (substance) |
Inferred relationship |
Some |
|
Fusidic acid 20 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fusidic acid (substance) |
Inferred relationship |
Some |
|
Product containing precisely fusidic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fusidic acid (substance) |
Inferred relationship |
Some |
|
Product containing fusidic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing fusidic acid in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fusidic acid (substance) |
Inferred relationship |
Some |
|
Sodium fusidate (substance) |
Is a |
False |
Fusidic acid (substance) |
Inferred relationship |
Some |
|
Product containing fusidic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
1 |
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fusidic acid (substance) |
Inferred relationship |
Some |
|
Product containing betamethasone and fusidic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
2 |
Accidental fusidic acid poisoning |
Causative agent (attribute) |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
1 |
Intentional fusidic acid poisoning |
Causative agent (attribute) |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
1 |
Fusidic acid 20 mg/g and hydrocortisone acetate 10 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fusidic acid (substance) |
Inferred relationship |
Some |
|
Product containing fusidic acid and hydrocortisone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing fusidic acid in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fusidic acid (substance) |
Inferred relationship |
Some |
|
Product containing fusidic acid in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
1 |
Allergy to fusidic acid |
Causative agent (attribute) |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
1 |
Sodium fusidate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
|
Fusidic acid 50 mg/mL oral suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
1 |
Fusidic acid 50 mg/mL oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fusidic acid 10 milligram/1 gram prolonged-release eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fusidic acid 10 milligram/1 gram prolonged-release eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
1 |
Fusidic acid 20 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
1 |
Fusidic acid 20 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fusidic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fusidic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
1 |
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
2 |
Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
2 |
Fusidic acid 20 mg/g and hydrocortisone acetate 10 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
1 |
Fusidic acid 20 mg/g and hydrocortisone acetate 10 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
1 |
Fusidic acid-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
1 |
Fusidic acid-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing betamethasone and fusidic acid in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing fusidic acid and hydrocortisone in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing only betamethasone and fusidic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing only fusidic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
1 |
Fusidic acid and hydrocortisone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
1 |
Fusidic acid and hydrocortisone only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
1 |
Fusidic acid only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
1 |
Fusidic acid only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing only fusidic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
1 |
Fusidic acid only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
1 |
Betamethasone and fusidic acid only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
2 |
Fusidic acid 10 mg/g eye drops suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
1 |
Fusidic acid 10 mg/g eye drops suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
1 |
Fusidic acid anhydrous |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Fusidic acid (substance) |
Inferred relationship |
Some |
|